Literature DB >> 7517956

An unusual epithelial pleomorphic giant cell tumour of the pancreas with osteoclast-type cells.

A Martin1, P Texier, J M Bahnini, J Diebold.   

Abstract

A case of giant cell tumour of the pancreas with a mixture of pleomorphic giant cells and osteoclast-like cells is described. This association is rare and its histogenesis has been debated. The presence of a small differentiated adenocarcinomatous area at the periphery of the tumour indicates an epithelial origin. Moreover, some pleomorphic cells were positive for keratin (KL1). The osteoclast-like cells strongly expressed CD68 (a marker of histiomonocytic lineage) and did not show proliferative activity. They probably correspond to an unusual reaction of the stroma. Their clinical importance in this type of tumour remains unknown.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7517956      PMCID: PMC501948          DOI: 10.1136/jcp.47.4.372

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Giant cell tumor of the pancreas of mixed osteoclastic and pleomorphic cell type: evidence for a histogenetic relationship and mesenchymal differentiation.

Authors:  K B Lewandrowski; L Weston; G R Dickersin; D W Rattner; C C Compton
Journal:  Hum Pathol       Date:  1990-11       Impact factor: 3.466

2.  Carcinoma of pancreas simulating giant cell tumor of bone. Electron-microscopic evidence of its acinar cell origin.

Authors:  J Rosai
Journal:  Cancer       Date:  1968-08       Impact factor: 6.860

3.  Giant cell tumor of the pancreas of the osteoclastic type associated with a mucous secreting cystadenocarcinoma.

Authors:  J A Posen
Journal:  Hum Pathol       Date:  1981-10       Impact factor: 3.466

4.  Giant cell tumor ("osteoclastoma") of the pancreas: a tumor of epithelial origin.

Authors:  R W Trepeta; B Mathur; S Lagin; V A LiVolsi
Journal:  Cancer       Date:  1981-11-01       Impact factor: 6.860

5.  Malignant fibrous histiocytoma (giant cell type) of the pancreas. A distinctive variant of osteoclast-type giant cell tumor of the pancreas.

Authors:  S Suster; M Phillips; M J Robinson
Journal:  Cancer       Date:  1989-12-01       Impact factor: 6.860

6.  Giant cell tumour (osteoclastoma) of the pancreas--an epithelial tumour probably of pancreatic acinar origin.

Authors:  S S Jalloh
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

7.  Osteoclast-type giant cell tumour of the pancreas.

Authors:  I Jeffrey; J Crow; B W Ellis
Journal:  J Clin Pathol       Date:  1983-10       Impact factor: 3.411

Review 8.  Osteoclast-type giant cell tumour of the pancreas.

Authors:  H P Fischer; M Altmannsberger; J Kracht
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

9.  The osteoclast-type giant cell tumor of the pancreas.

Authors:  R C Berendt; T K Shnitka; E Wiens; V Manickavel; L D Jewell
Journal:  Arch Pathol Lab Med       Date:  1987-01       Impact factor: 5.534

  9 in total
  3 in total

1.  Osteoclastic and pleomorphic giant cell tumors of the pancreas: A review of clinical, endoscopic, and pathologic features.

Authors:  Jill C Moore; Joel S Bentz; Kristen Hilden; Douglas G Adler
Journal:  World J Gastrointest Endosc       Date:  2010-01-16

2.  A case of osteoclast-like giant cell tumor of the pancreas with ductal adenocarcinoma: histopathological, immunohistochemical, ultrastructural and molecular biological studies.

Authors:  Young-Eun Joo; Tag Heo; Chang-Hwan Park; Wan-Sik Lee; Hyun-Soo Kim; Jung-Chul Kim; Yang-Seok Koh; Sung-Kyu Choi; Chol-Kyoon Cho; Jong-Sun Rew; Sei-Jong Kim
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

3.  Long-term survivor of a resected undifferentiated pancreatic carcinoma with osteoclast-like giant cells who underwent a second curative resection: A case report and review of the literature.

Authors:  Shinjiro Kobayashi; Hiroshi Nakano; Nobuyuki Ooike; Masaki Oohashi; Satoshi Koizumi; Takehito Otsubo
Journal:  Oncol Lett       Date:  2014-07-08       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.